D. Lachance

Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.

Barry I. Posner, Robert Faure, J.W. Burgess et al. · Journal of Biological Chemistry · 1994 · 537 citations · Full text

Reclassification of prosthesis–patient mismatch after transcatheter aortic valve replacement using predicted vs. measured indexed effective orifice area

Julien Ternacle, Leonardo Guimarães, Flavien Vincent et al. · European Heart Journal - Cardiovascular Imaging · 2020 · 58 citations

In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency

A. Paul Bevan, J.W. Burgess, J. F. Yale et al. · American Journal of Physiology-Endocrinology and Metabolism · 1995 · 37 citations

Treatment of Combined Aortic Regurgitation and Systemic Hypertension: Insights From an Animal Model Study

Jacques Couët, Martin Gaudreau, D. Lachance et al. · American Journal of Hypertension · 2006 · 17 citations